|
BLOC1S1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.515700E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.733800E-01 |
| Normal-vs-Stage2 |
9.707600E-02 |
| Normal-vs-Stage3 |
1.516270E-02 |
| Normal-vs-Stage4 |
1.344350E-02 |
| Stage1-vs-Stage2 |
1.742160E-01 |
| Stage1-vs-Stage3 |
7.511700E-02 |
| Stage1-vs-Stage4 |
5.254400E-02 |
| Stage2-vs-Stage3 |
5.149600E-01 |
| Stage2-vs-Stage4 |
7.056600E-01 |
| Stage3-vs-Stage4 |
6.301800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.907700E-02 |
| Normal-vs-AfricanAmerican |
3.258600E-03 |
| Normal-vs-Asian |
4.126800E-01 |
| Caucasian-vs-AfricanAmerican |
1.802310E-02 |
| Caucasian-vs-Asian |
7.331600E-01 |
| AfricanAmerican-vs-Asian |
6.110200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.365600E-02 |
| Normal-vs-Female |
1.201770E-02 |
| Male-vs-Female |
7.574200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.227020E-01 |
| Normal-vs-Age(41-60Yrs) |
3.327800E-02 |
| Normal-vs-Age(61-80Yrs) |
8.085700E-02 |
| Normal-vs-Age(81-100Yrs) |
1.034190E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.841000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.566600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.083800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.439400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.888640E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.614020E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.084800E-01 |
| Normal-vs-Grade 2 |
2.365600E-01 |
| Normal-vs-Grade 3 |
9.784700E-03 |
| Normal-vs-Grade 4 |
4.523000E-03 |
| Grade 1-vs-Grade 2 |
3.965000E-01 |
| Grade 1-vs-Grade 3 |
2.730000E-01 |
| Grade 1-vs-Grade 4 |
3.314000E-02 |
| Grade 2-vs-Grade 3 |
2.538600E-01 |
| Grade 2-vs-Grade 4 |
4.396100E-02 |
| Grade 3-vs-Grade 4 |
1.831770E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.056200E-01 |
| Normal-vs-ccB subtype |
5.159800E-02 |
| ccA subtype-vs-ccB subtype |
8.897800E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.723590E-02 |
| Normal-vs-N1 |
1.463560E-01 |
| N0-vs-N1 |
2.710600E-01 |
|
|
